These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 9789212

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Depressive symptoms and biogenic amines as predictors of treatment response in schizophrenic illnesses in childhood and adolescence].
    Fleischhaker C, Schulz E, Remschmidt H.
    Z Kinder Jugendpsychiatr Psychother; 1998 Dec; 26(4):235-43. PubMed ID: 9880833
    [Abstract] [Full Text] [Related]

  • 3. Blood biogenic amines during clozapine treatment of early-onset schizophrenia.
    Schulz E, Fleischhaker C, Clement HW, Remschmidt H.
    J Neural Transm (Vienna); 1997 Dec; 104(10):1077-89. PubMed ID: 9503259
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clozapine in the treatment of a young adolescent with schizophrenia.
    Jacobsen LK, Walker MC, Edwards JE, Chappell PB, Woolston JL.
    J Am Acad Child Adolesc Psychiatry; 1994 Jun; 33(5):645-50. PubMed ID: 8056727
    [Abstract] [Full Text] [Related]

  • 8. Clozapine treatment in very early onset schizophrenia.
    Mozes T, Toren P, Chernauzan N, Mester R, Yoran-Hegesh R, Blumensohn R, Weizman A.
    J Am Acad Child Adolesc Psychiatry; 1994 Jan; 33(1):65-70. PubMed ID: 8138523
    [Abstract] [Full Text] [Related]

  • 9. A randomized trial comparing clozapine and typical neuroleptic drugs in non-treatment-resistant schizophrenia.
    Meltzer HY, Bobo WV, Lee MA, Cola P, Jayathilake K.
    Psychiatry Res; 2010 May 30; 177(3):286-93. PubMed ID: 20378185
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Atypical neuroleptics in the child and adolescent].
    Naja WJ, Reneric JP, Bouvard MP.
    Encephale; 1998 May 30; 24(4):378-85. PubMed ID: 9809243
    [Abstract] [Full Text] [Related]

  • 15. Clinical predictors of therapeutic response to clozapine in a sample of Turkish patients with treatment-resistant schizophrenia.
    Semiz UB, Cetin M, Basoglu C, Ebrinc S, Uzun O, Herken H, Balibey H, Algul A, Ates A.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug 15; 31(6):1330-6. PubMed ID: 17618026
    [Abstract] [Full Text] [Related]

  • 16. Clozapine for early developmental delays with childhood-onset schizophrenia: protocol and 15-month outcome.
    Towbin KE, Dykens EM, Pugliese RG.
    J Am Acad Child Adolesc Psychiatry; 1994 Jun 15; 33(5):651-7. PubMed ID: 7520035
    [Abstract] [Full Text] [Related]

  • 17. First-episode neuroleptic-free schizophrenics: concentrations of monoamines and their metabolites in plasma and their correlations with clinical responses to haloperidol treatment.
    Nagaoka S, Iwamoto N, Arai H.
    Biol Psychiatry; 1997 Apr 15; 41(8):857-64. PubMed ID: 9099412
    [Abstract] [Full Text] [Related]

  • 18. Clozapine-induced electroencephalogram changes as a function of clozapine serum levels.
    Freudenreich O, Weiner RD, McEvoy JP.
    Biol Psychiatry; 1997 Jul 15; 42(2):132-7. PubMed ID: 9209730
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.